C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) A61K 31/70 (2006.01) C07H 21/00 (2006.01) C07K 14/82 (2006.01) C12N 9/02 (2006.01) C12N 15/11 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2111472
2111472 9222651 PCTABS00018 Compositions and methods are provided for the modulation of expression of the human ras gene in both the normal and activated forms. Oligonucleotides are provided which are specifically hybridizable with RNA or DNA deriving from the human ras gene, having nucleotide units sufficient in identity and number to effect such specific hybridization. Oligonucleotides or oligonucleotide analogs specifically hybridizable with a translation initiation site or with the codon-12 mutation of activated ras are provided. Such oligonucleotides and oligonucleotide analogs can be used for diagnostics as well as for research purposes. Methods are also disclosed for modulating ras gene expression in cells and tissues using the oligonucleotides or oligonucleotide analogs provided, and for specific modulation of expression of the activated ras gene. Methods for diagnosis, detection and treatment of conditions arising from the activation of the H-ras gene are also disclosed.
Ecker David J.
Freier Susan M.
Monia Brett P.
Borden Ladner Gervais Llp
Isis Pharmaceuticals Inc.
LandOfFree
Antisense oligonucleotide inhibition of the ras gene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense oligonucleotide inhibition of the ras gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotide inhibition of the ras gene will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1852399